2026 ICD-10-CM Diagnosis Code H35.3232Exudative age-related macular degeneration, bilateral, with inactive choroidal neovascularization
ICD-10-CM Codes›H00–H59›H30-H36›H35
- Billable — Valid for Submission
- 7th Character 2
- Chronic Condition
H35.3232 is a billable ICD-10-CM diagnosis code for exudative age-related macular degeneration, bilateral, with inactive choroidal neovascularization. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRG 124 through 125. The code is restricted by the Medicare Code Editor to adult patients (age 15 through 124). In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Retinal and vitreous conditions.
Code Identity
Code Classification
Code EditsBilling
Medicare Code Editor checks that affect claim validity for H35.3232.
Clinical ClassificationClinical
AHRQ’s CCSR groups this code into broader clinical categories.
Patient EducationClinical
Macular Degeneration
Macular degeneration, or age-related macular degeneration (AMD), is a leading cause of vision loss in Americans 60 and older. It is a disease that destroys your sharp, central vision. You need central vision to see objects clearly and to do tasks such as reading and driving.
Read the full article at MedlinePlus
Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.
Convert H35.3232 to ICD-9-CMHistory
The closest ICD-9-CM equivalents under the General Equivalence Mappings.
Code History & ChangesHistory
Replacement H35.3232 replaces the following previously assigned code(s):
- H35.32 - Exudative age-related macular degeneration
Questions About H35.3232Overview
Is H35.3232 (Exudative age-related macular degeneration, bilateral) a billable code?
Yes. This is a billable ICD-10-CM code, specific enough to report exudative age-related macular degeneration, bilateral, with inactive choroidal neovascularization on HIPAA-covered claims from October 1, 2025 through September 30, 2026.
What MS-DRG does H35.3232 group to?
When exudative age-related macular degeneration, bilateral, with inactive choroidal neovascularization is the principal diagnosis on an inpatient stay, it groups to MS-DRG 124, 125, with relative weights from 0.7678 to 1.3231 depending on complications. Higher weights mean higher Medicare reimbursement.
Who can H35.3232 be reported for?
The Medicare Code Editor checks exudative age-related macular degeneration, bilateral, with inactive choroidal neovascularization against patient demographics: this code is intended for adult patients (age 15 through 124). Claims outside these limits are flagged as inconsistent.
What is the ICD-9 equivalent of H35.3232?
Under the General Equivalence Mappings, exudative age-related macular degeneration, bilateral, with inactive choroidal neovascularization converts to ICD-9-CM 362.52 (exudative macular degen). The mapping is approximate, so confirm the match fits the documentation.
Footnotes
[1] Chronic - a chronic condition code indicates a condition lasting 12 months or longer and its effect on the patient based on one or both of the following criteria:
- The condition results in the need for ongoing intervention with medical products,treatment, services, and special equipment
- The condition places limitations on self-care, independent living, and social interactions.
